Silverarc Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $15M | Buy |
|
|||||
|
2024
Q3 | $12.2M | Sell |
|
|||||
|
2024
Q2 | $13.2M | Buy |
|
|||||
|
2024
Q1 | $2.41M | Sell |
|
|||||
|
2023
Q4 | $5.73M | Sell |
|
|||||
|
2023
Q3 | $10.9M | Buy |
|
|||||
|
2023
Q2 | $12.6M | Buy |
|
|||||
|
2023
Q1 | $6.77M | Sell |
|
|||||
|
2022
Q4 | $7.43M | Buy |
|
|||||
|
2022
Q3 | $6.33M | Sell |
|
|||||
|
2022
Q2 | $17.9M | Buy |
|
|||||
|
2022
Q1 | $18.9K | Buy |
|
|||||
|
2021
Q4 | $10.2M | Buy |
|
|||||
|
2021
Q3 | $3.8M | Sell |
|
|||||
|
2021
Q2 | $4.62K | Sell |
|
|||||
|
2021
Q1 | $4.42M | Sell |
|
|||||
|
2020
Q4 | $6.36M | Buy |
|